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The object of this paper is to describe attempts at determining the 
minimal quantity of the virus of equine encephMomyelitis needed for 
producing resistance to experimental infection of guinea pigs by way 
of the nose, skin, and brain.  With this known, a basis has been con- 
structed for comparing the immunizing capacity of virus preparations. 
The Eastern and Western strains were employed in this study in three 
forms: adsorbed on alumina gel; precipitated by tannin; and chemically 
untreated, merely passaged through a series of mice. 
Evidence has been brought forward by several investigators  (1) to show that 
active virus of equine encephalomyelitis immunizes horses and guinea pigs against 
experimental  infection.  Shahan and Giltner  (2)  report that protection can be 
secured by means of formolized infected  tissue which, they believe, contains in- 
activated virus.  Others,  on the contrary, state that inactive  material  is appar- 
ently ineffective (Howitt, 1; Rosenbusch,  1). 
The experiments on immunity with active, untreated virus passaged 
through a large series of white mice will be described first? 
Active,  Untreated  Virus as Immunizing Substance 
It is known that certain viruses, after repeated animal passage, are 
reduced or modified in their infectivity for the original host and hence 
can be used' for immunization (3).  Besides the pox diseases, other 
maladies, as, e.g.,  rabies (3), horse sickness (4), yellow fever (5),  and 
psittacosis  (6),  have  been  successfully  prevented  by  means  of 
adapted material.  Traub and TenBroeck (1) have recently reported 
t Operations on animals were made with the aid of ether anesthesia. 
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the immunization  of  guinea  pigs and  horses with pigeon-modified, 
equine encephalomyelitis virus (7). 
TABLE  I 
The Comparative Susceptibility of Mice and Guinea Pigs to Intracerebral Injection 
of tke Same Quantities of Mouse Passaged Virus 
Virus dilution 
10--~ 
10  4 
10-7 
10-s 
10-9 
Mice 
6/6 
6/6 
1/6 
0/6 
0/6 
Result 
Guinea pigs 
4/4 
4/4 
1/4 
o/4 
o/4 
Quantity  ffi 0.03 cc. 
Numerators represent number of animals that succumbed to infection; denomi- 
nators, number of animals employed in the test. 
TABLE  II 
Guinea Pig Brain  Virus Injected Subcutaneously in Guinea Pigs 
Time after  Virus dilution 
injection 
d~y$ 
I 
2 
3 
4 
5 
6 
7 
8 to 
21 
10  ~ 
--T 
101.4 
104.5 
100.8 
102.7 
D 
10-_.____[_'  10-__..~, 
OF"  I  OF" 
102.5  I 101.6 
104.6  I 101.2 
102.4  I 101.8 
105.8  [ 101.8 
100.3  [ 100.6 
D  102.4 
101.6 
10~.3 
10-4 
102.4 
10g.4 
102.4 
104.6 
D 
10t 
101.8 
105.0 
101.6 
102.4 
105.4 
D 
10-6  10-1  10-e  10-~ 
TIT T  T  -- 
102.41 102.0  102.0  101.4 
105.3[  101.8  105.4  102.7 
102.3[  102.11  D  I 101.9 
102.4[  102.3  103.0 
101.6[  101.6  101.7 
102.1[  101.1  102.2 
102.8[  102.0  102.0 
103.0  102.9  10~.9 
S  S 
10-~ 
OF. 
101.4 
102.2 
102.8 
102.8 
101.8 
103.0 
104.6 
D 
Weight of animals  =  275 to 325 gun. 
D  =  died of experimental encephalitis. 
S  =  survived and apparently normal 
Source of Virus.--The  Eastern  and Western  strains,  ultimately derived from 
affected horses and propagated in guinea pigs, were transferred  to the brain of 
mice.  The virus was passed serially in this way from mouse to mouse until the 
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diminished pathogenicity after injection in the subcutis of guinea pigs.  This was 
not true as concerns injections into the brain.  To illustrate, the same quantity of 
mouse brain virus as before (0.03 cc.) was lethal intracerebrally in mice and guinea 
pigs in dilutions of  10 -4 to  10 -~ inclnsive.  It was now, however, not disease- 
producing when  1 cc. of these dilutions was injected subcutaneously in guinea 
pigs.  By contrast, guinea pig brain virus, before mouse passage, was active in 
guinea pigs when  given subcutaneously, regularly in dilutions up  to  10 -a and 
occasionally up to 10 -7 (see Tables I, II, and III which summarize the results of 
such titrations and are examples of repeated observations). 
Preparation of Material.--For use as antigen the brains of mice which succumbed 
to mouse passage virus were removed aseptically and ground to a 10 per cent sus- 
TABLE  III 
(For Comparison witk Table I1) 
Tke Results of Mouse Adapted Virus Injected Subcutaneously in Guinea Pigs 
Weighing 275 to 350 Gin. 
Time 
after 
Uon 
days 
1 
2 
3 
4 
5 
6to 
21 
Virus dilution 
10  ~  10  -3  10-4  10-4 
°F.  oF.  °P.  °F. 
102.8 102.6 103.4 104A 
105.5 105.8 104.6 104A 
102.4 104.4 102.5 103 .~ 
101.0 102.5 101.2 102 .~ 
103.8 103.7 103.4 104.1 
s  s  s  s 
10-5 
OF. 
102.6 
103.3 
102.0 
101.5 
103.6 
S 
lO-I 
°F. 
103.0 
103.5 
103.0 
102.0 
103.7 
S 
lO--e 
*F. 
103.9 
103.4 
103.0 
102.6 
103.2 
S 
10-t 
'T. 
101.8 
103.8 
101.6 
101.2 
104.0 
S 
10-~ 
°F. 
103.5 
103 .C 
101.5 
102.C 
103.3 
S 
10-¢ 
W. 
103.7 
103.2 
101.3 
101.4 
103.9 
S 
10-5  10s 
°F.  °F. 
0/4  0/4 
4/4  2/4 
4/4 
10  ~  lO"t 
°P.  -°F. 
0/4  0/4 
O/4  0/4 
3/4  1/4 
3/4  1/4 
3/4  2/4 
4/4  2/4 
At right of double line is shown a simultaneous titration of virus by intracerebral 
inoculation of mice; the numerator represents number of mice that died of the 
experimental disease; the denominator, the number of animals employed in the 
test. 
pension in broth.  The suspension was spun in an angle centrifuge at 3,000 R.P.K. 
for ! 5 minutes and the required dilutions were prepared from the supernatant fluid. 
This constituted fresh material, but it was often desired to inject an~m~1.~ with 
known quantities of virus and to repeat the injection at weekly intervals; hence 
the material had to be maintained in undiminished concentration.  Two methods 
of preservation were employed: merthiolate and  desiccation.  Of  the  two,  the 
latter was preferable since the virus content did not diminish as rapidly over long 
periods of time. 
A 2 per cent suspension of infected mouse brains in Tyrode's solution, pH 7.6, 
containing merthiolate 1:5,000 was made.  The suspension was filtered through 
8 ply sterile gauze, diluted with three volumes of sterile, distilled water, and stored 314  IMMUNIZATION  WITH  ENCEPHALOMYELITIS  VIRUS.  I 
in the cold.  The material, which contained 300,000 mouse infective units (here- 
after called m.i.u.) ~ per cc.  immediately after its preparation, was  found  after 
storage for 4½ months to contain 3,000 m.i.u, per cc. of virus.  Desiccated material 
was obtained as follows: Mouse brains removed from animals before death were 
ground to a  l0 per cent suspension in Tyrode's solution, pH 7.6, or in l0 per cent 
normal  rabbit  serum  diluted with  Tyrode's solution.  After centrifugation at 
4,000 R.P.~. in an angle machine for 20 minutes, the superuatant fluid was removed 
and tubed in 1½ cc. quantities and dried in va~uo in the cold over sulfuric acid. 
Dried virus, after storage for 12 weeks, still contained the original amount of the 
active agent  (usually 3  X  l05 to 3  X  l0  s m.i.u, per cc. of resuspended material). 
The effect of longer storage on dried virus has still to be determined. 
The two strains, Eastern and Western, prepared separately or mixed in the same 
specimen, exhibited no noticeable difference in immunizing power. 
Dosage.--All virus samples were  titrated before use by mouse  intracerebral 
inoculation.  In this way the number  of m.i.u,  of virus was determined.  For 
preventive inoculation of guinea pigs 1 cc. was injected subcutaneously and, when 
indicated, repeated at 7 to 13 day intervals.  Control guinea pigs and mice were 
included in each experiment to measure the activity of varying dilutions of virus 
by means of inoculation intracerebraUy, or subcutaneously, or by instillation in- 
tranasally (see Tables I  to III for a pattern of such titrations). 
Test for Resistance.--Although guinea pigs were immunized with mouse passage 
virus, they received as test dose for induced resistance guinea pig brain passage 
virus, as did all animals throughout  this study. 
An intracerebral test was found to be more drastic than an intranasal or a sub- 
cutaneous one.  To  illustrate, guinea pigs received subduraUy 0.12  cc., subcu- 
taneously, 1 cc., or intranasaUy, 0.1  cc. of virus suspension.  With the volumes 
used, normal guinea pigs reacted with characteristic lethal encephalitis in limit- 
ing dilutions of 10 -6 or even 10 -7 after intracerebral inoculation; and the same 
happened with  10 -3  on subcutaneous  injection, and with dilutions of  1:100 to 
1:200 after intranasal instillation.  Therefore,  to determine induced resistance, 
103 to 104 M.L.D. were introduced into the brain, whereas in the skin or nose, lightly 
centrifuged, 10 per cent fresh virus suspension was employed, representing 1 to 
10 U.LD. 
Effect of Storage.--The virus employed as immunizing agent was still effective 
after it had been stored in the cold for 3 months, at least. 
A  mouse infective unit  (m.i.u.)  is defined as  the minimal amount  of virus 
which, after intracerebral inoculation of mice, induces lethal encephalitis.  If, for 
example, the highest active dilution is 10 -8 (all dilutions are in terms of weight of 
infective tissue), then 10 -5 represents 103 or 1,000 m.i.u.  Since mice receive only 
0.03 cc. intracerebrally, 1 cc. contains about 30 times as many units.  Thus, 1 cc. 
of a  10 -s dilution should have approximately 30,000 m.i.u. PETER  K.  OLITSKY  AND  HERALD  R.  COX  315 
Immunization  with Mouse Passage  Virus.--We  first sought  to find 
the  minimal  amounts  and  number  of doses  necessary for  active  im- 
munization against the intracerebral test dose.  Table IV summarizes 
the  experiments. 
TABLE  IV 
The Relation of Amount of Mouse Passage Virus and Number of Doses to the 
Production of Resistance against IntracerebraI Test Inoculation 
7 
7 
8 
8 
2 
12 
3 
7 
9 
7 
2 
20 
2 
41 
6 
11 
9 
19 
7 
11 
9 
8 
9 
Animals  Animals  Immunity test (4 to 6  wks. 
sho  "  later)  No. of  M.i.u. in  feverW~r  o~  showing  weekly  •  •  virus In  injections  each dose  104 ° or  blood 
above 
No. of 
animals 
injected 
3  X  lO  s 
3 X  10  7 
3X100 
3  X  10  5 
3X10 6 
3XlO s 
3X100 
3X10 5 
3X  100 
3X100 
3X100 
3X100 
3X100 
3X100 
3X100 
3X100 
3X100 
3X100 
3XlO ~ 
3X  lO  s 
3X  100 
3X100 
3 X  10  a 
Animals 
dying of in- 
fection 
during im- 
mun~mg 
period 
4 
2 
1 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
7 
7 
7 
2 
1 
4 
2 
3 
2 
2 
0 
4 
0 
3 
0. 
0 
0 
0 
0 
0 
0 
0 
0 
Sur o 
x.L.v.  Died  vived 
10~-100  1  2 
100-100  0  5 
100-100  I  1  6 
100-100  ~  0  8 
10~100  0  2 
100-10'  [  2  10  i 
10L-100  ~  0  3 
100--100  0  7 
10'-100]  6  3 
100-10'  4  3 
100-100  2  0 
103-104  10  10 
100--i0  a  0  2 
100-100  0  41 
10~100  6  0 
10~100  7  4 
100-100  4  5 
10'-10  0  0  19 
100--100  7  0 
104-10'  11  0 
100-100  9  :  0 
100-100  6  2 
100-10'  9  1  0 
Reference  to  the  table  shows  that  lessened  resistance  occurred  in 
animals treated  with  amounts  of virus  smaller than  3  X  10  8 m.i.u., 
and  even  with  this  amount  if  it  was  given  less  than  three  times. 
Larger  quantities,  i.e., more  than  3  X  10  4 m.i.u.,  injected less than 
three times, were also effective in developing immunity but the danger 
then arose of increasing correspondingly the incidence of fever, circu- 316  IMMUNIZATION  WITH  ENCEPHALOMYELITIS  VIRUS.  I 
lating virus,* and death during the period of immunization.  In other 
words, it was essential that the preventive dose should confer protec- 
tion with the use of the least possible amount of virus, thus minimizing 
febrile reactions and blood infection.  This dose has been determined 
as 3  X  108 to 3  ×  104 m.i.u,  injected subcutaneously three times at 
weekly intervals.  It will be noted that  absence of fever during the 
period of immunization  does not necessarily foretell a  diminution  in 
the degree of induced protection. 
Immunization against Nasal and Subcutaneous Infection.--The next 
series of experiments  (Table V) reveals that protection against nasal 
and  subcutaneous test injections can be secured by means of one or 
two subcutaneous injections, each containing 3  X  10  4 m.i.u,  of virus. 
At this point, the fact should be mentioned that normal mice and 
guinea  pigs  receiving  virus  nasally  and  resisting  infection  may  be 
susceptible to a later nasal instillation.  Again, animals injected sub- 
cutaneously once or twice with smaller amounts of active virus are 
refractory to the nasal test but may succumb to the disease after a 
later intracerebral inoculation.  Apparently intranasal  application of 
virus  fails  to increase  the  degree  of resistance.  This  is  in  striking 
agreement with the results obtained by Jungeblut and Hazen (8) and 
by Flexner (9) in studies on experimental poliomyelitis in the monkey. 
As stated by Flexner,  refractory monkeys which resist not only one 
but several courses of nasal instillations of poliomyelitis virus develop 
no indication  of either active or passive immunity. 
In summing up the series in which untreated mouse passage virus 
was used as immunizing agent, it appears that a  sufficient amount of 
the material and its periodic inoculation are required to produce effec- 
tive protection.  The sufficient amount has been measured as 3 X  10  3 
to 3  X  10  4 m.i.u.:  one or two such doses given subcutaneously protect 
* The usual procedure for detecting circulating virus is limited in application, 
since 0.03 cc. of blood derived from an affected guinea pig, usually during the 
height of fever, or from the 2nd to 5th day after the primary injection, is intro- 
duced into the brain of each of four or six mice for the specimen to be examined. 
While positive reactions are unequivocal, negative ones are less significant for 
only a small amount of blood is put to test.  However, these tests were made with 
the purpose of comparing the results obtained in each series of animals treated with 
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guinea pigs against experimental subcutaneous or intranasal infection 
and three doses, given at weekly intervals, against intracerebral test 
inoculation of 103 to 104 lethal units.  Further, fever occurred in only 
eleven of 126 animals given this dosage, and in only one instance was 
TABLE  V 
Protection Test Given by Way of Nose and Subcutis 
No. of sub- 
cutaneous  Test for resistance given 
injections  Strain and m.i.u, in  14 to 21 clap,  s after last immu-  Given by way  Result* 
of mouse  each dose  mzmg dose  of 
virus 
1  1-5 ~.L.D.  Subcutis  1/3  Eastern  =3  X  10  4 
Western =  3  X  10  3 
Eastern  =3  X  1@ 
Western =  3  X  10  3 
Eastern  =3  X  10 4 
Eastern  =3  X  103 
1-5 M.L.D. 
1--5 M.L.D.  on  2  occa- 
sions, 4 days apart 
1--5 M'.L.D.  on  2  occa- 
sions, 5 days apart 
Nose 
Eastern  --  3  X  10' 
Eastern  =3  X  10  4 
Eastern  =3  X  10  4 
1-5 M.L.D. 
1-5 M.L.D. 
1-5 M.L.D. 
Subcutis 
Nose 
Subcutis 
Eastern  =  3  X  10  4  Tested on 2  occasions 4  Nose 
days apart 
2/3 
116 
3/7 
2/22 
1/11 
o11o 
1/5t 
* Fractions defined in Table I; of thirty control guinea pigs used, twenty-seven 
died  of  characteristic  encephalitis  after  nasal  or  subcutaneous  injection  of  the 
test dose. 
t  These six guinea pigs withstood an intranasal test 16 days after the last pre- 
ventive dose was inoculated but one of them died after all had received a  second 
intranasal test 4 days later. 
the febrile reaction accompanied by the presence of virus in the blood 
as determined by our method.  The incidence of fever and of blood 
infection increases in those animals receiving larger amounts of virus-- 
quantities  in  excess  of  what  is  needed for  building up  resistance. 
Mter storing,--the longest period thus far being 3 months,--the im- 318  IMMUNIZATION  WITH  ENCEPHALOMYELITIS  VIRUS.  I 
munizing agent still contained an adequate amount of virus for the pro- 
duction of uniform resistance to the usual intracerebral test.  Finally, 
the  protection  acquired  is  durable,  lasting  throughout  at  least  3 
months. 
Adsorbed Virus as Immunizing Preparation 
Aluminum hydroxide, Type C, first employed by Willstaetter  (10) 
to purify enzymes, was chosen as the  agent for adsorption  (11).  It 
was shown in a preliminary report (12) that the material adsorbed the 
encephalomyelitis  virus  and  then  could  induce  active  protection  in 
guinea pigs.  The subject has since been more extensively elaborated 
and the results of this work are now presented. 
Mouse rather than guinea pig passage virus was used in preparing vaccines for 
guinea pigs.  It has already been pointed out (see also Tables II and III) that the 
mouse passage virus consistently displays a lesser degree of infectivity following 
subcutaneous injection of guinea pigs.  In general, the methods employed with 
adsorbed virus were the same as those described in the foregoing section. 
Preparation of Adsorbed Virus.--The brains of three mice which succumbed to 
experimental encephalomyelitis were ground in ~t/50  phosphate buffer, pH 6.6, 
to a 10 per cent suspension.  This was centrifuged at 1500 mp.~t, for 25 minutes. 
To 2 cc. of the supernatant fluid were added 98 cc. of the Gel C (about 2 mg. A1203 
per cc. of buffer).  The mixture, which then consisted of active tissue in a dilution, 
by weight, of 1 : 500, was vigorously shaken and kept in the cold for 24 hours.  It 
was next centrifuged and the deposit washed three times with 150 cc. of the buffer 
each time.  Emphasis was laid on thorough washing, since insufficient  cleansing 
might not have removed the excess, or unadsorbed, virus.  The precipitate was 
resuspended in 200 cc. of Tyrode solution, pH 7; thereupon the suspension con- 
tained A12Os in a concentration of 1 rag. per ec. 
When tissue cultures were used as antigens, 16.5 cc. of each cultured strain, after 
centrifuging to remove most of the cells, were added to 8.25 cc. of the gel (7.5 nag. 
per cc. of buffer).  The mixture was thoroughly shaken and kept cold overnight. 
The alumina was sedimented by centrifugation and the deposit was washed thrice 
in 100 cc. of the buffer.  It was then suspended in 80 cc. of Tyrode's solution pH 7; 
thus the concentration of A1,Oa remained approximately 0.75 rag. per co. 
When both final products were titrated by means of the mouse intracerebral 
tests, they were found to contain 3 ×  l0  s to 3  ×  10  4 m.i.u, of virus. 
Western or Eastern strains, or both combined, differed in no way in antigenic 
power. 
Inactivation of Virus.--A significant point is that the vaccines were not disease- 
producing as they were ordinarily employed; yet, when they were inoculated in 
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characteristic  lethal  encephalitis  ensued.  Moreover,  active virus was recovered 
from the cutaneous  nodules produced by injection  of alumina  material.  Clearly 
then, the adsorption  process as carried out did not inactivate the infective agent. 
The Local Reaction.--The local reaction  that developed at the site of injection 
was referable to the presence of the gel, for no distinction  could be made between 
this reaction  and the one induced by aluminum hydroxide alone.  It is not im- 
probable that the reaction is characteristic  of the general group of insoluble chemi- 
cal agents used as adsorbents.  The alumina as such persisted beneath the skin for 
at least 3 weeks, during which time there was marked phagocytosis  by polynuclear 
and monocytic ceils.  Later the involved area showed formation of granulation 
tissue including giant ceUs, together with invasion by lesser numbers of the leuco- 
cytes.  Gradual  retrogression  in size occurred  thereafter until the nodule  disap- 
peared in the 5th or 6th week.  In instances  in which 7.5 nag. or more of A1208 
were used, a late sterile abscess supervened  foUowed by ulceration,  discharge of 
contents,  and finally, healing by "secondary intention." 
Although the gel virus  in the immunizing  dose did not produce encephalitis 
after subcutaneous  inoculation,  the infective  agent was recovered  from nodules 
excised on the 2nd and 4th but not on the 7th day after injection or later.  The 
method employed  for recovering  the active agent from the lesions consisted  in 
grinding the excised nodules to a fine pulp in a minimal amount of Tyrode solution 
and injecting it into the brains of six mice for each sample.  No attempts at elution 
of the virus from the gel were made. 
Effect of Storage.--The adsorbed material  still retained  its immunizing capacity 
after being stored in the cold for 2½ and 6 months--the longest periods studied-rat 
which time it still contained virus.  This was manifested by the lethal encephalitis 
induced  in all of five mice after its intracerebral  inoculation.  How much virus 
was present  could not be told since it was not found possible to elute the infective 
agent from the gel.  In a sample which was stored for 5 weeks, however, a content 
of 3  ×  104 m.i.u, was noted. 
Immunization with Adsorbed Virus.--Proceeding  as with the chemi- 
cally untreated mouse virus, we attempted to determine the minimal 
immunizing dose of the adsorbed material. 
Since it was difficult to elute the virus and titrate its concentration precisely, we 
undertook an experiment in which known quantities  were added to the adsorbent, 
Gel C, and then used for immunization  (Table VI). 
One may infer that  3  ×  10  4 m.i.u,  of adsorbed virus in  repeated 
doses are as adequate for immunization as like amounts of unadsorbed, 
mouse passage virus. 
Immuni,.ation  against Nasal, Subcutaneous,  and Intracerebral Tests.--When  a 
dose of 3 ×  103 to 3 ×  104 m.i.u, was injected subcutaneously,  it was found to ira- 320  IMMUNIZATION  WITH  ENCEPHALOMYELITIS  VIRUS.  I 
munize guinea pigs to experimental nasal or subcutaneous infection, as shown in 
Table VII.  For protection against the intracerebral  test, three such injections 
were required, just as was found to be the case when unadsorbed virus was used. 
On the other hand, if 3 cc. of adsorbed material were given in one inoculum, instead 
of 1 cc. in three doses, then febrile reactions arose, accompanied by the presence 
of virus in the blood.  For example, in one series of six guinea pigs receiving a single 
large inoculum, two animals died of virus infection and three of the four survivors 
succumbed to the usual intracerebral test (see also Table IV).  This finding is in 
TABLE  VI 
The Immunizing Capacity of Different Amounts of Virus Adsorbed on Alumina 
No. of weekly subcu-  Test for resistance* 
taneous injections  M.i.u. in each dose  given intracerebrally  Resultt 
about 1 month later 
2 
3 
2 
3 
2 
3 
2 
3 
2~ 
3 
<3 X  101 
<3 X  101 
>3  X  101 
>3 X  101 
>3 X  10  2 
>3 X  10  2 
>3  X  10  3 
>3  X  10  3 
>3  X  104 
>3  X  104 
M.L.D. 
> 10  4 
>104 
>104 
>lif  t 
>104 
>104 
>104 
>104 
>104 
>10  4 
3/3 
3/3 
3/3 
3/3 
3/3 
2/3 
3/3 
1/3 
0/3 
0/3 
* In the test for acquired resistance, the guinea pig brain passage virus which 
was employed induced lethal encephalitis in all of six guinea pigs inoculated intra- 
cerebrally with 1 : 50 to 1 : 500,000  dilutions and in all of nine mice receiving dilu- 
tions only to 1:5,000. 
t  Fractions defined in Table I. 
For the comparative observations on the capacity of one, two, and three injec- 
tions to produce resistance to an intracerebral test inoculation, see similar experi- 
ments cited in Table VII. 
agreement with what occurs when a similar injection of unadsorbed virus is given. 
It is plain that safer and more effective protection follows the use of repeated, small 
quantities of virus. 
Febrile Reactions and Circulating  Virus.--Eleven of forty-six animals receiving 
3  ×  lif  t m.i.u, of virus responded with fever, and of the eleven only two had blood 
infection.  The  incidence of febrile reactions and  of  circulating virus became 
greater with larger doses just as with unadsorbed virus. 
An  analysis of the experiments with alumina  adsorbed virus leads 
to  the  conclusion  that  there  is little, if  any,  difference in  the  effects PETER  K.  OLITSKY  AND  HERALD  R.  COX  321 
of the  mouse passage,  unadsorbed virus and  of the  Gel  C  adsorbed 
material  respectively.  A  lesser rate of absorption in vivo of the ad- 
sorbed virus could not be discerned.  Indeed, it was shown that the 
adsorption process as here employed does not inactivate the infective 
agent and that an adequate amount of the alumina material, that is, 
adequate in antigenic capacity yet within the range of least constitu- 
tional  disturbances  of fever and  of circulating virus,  is  the  same  as 
with living mouse passage virus,--3  ×  103 to  3  X  104 m.i.u,  given 
three times at weekly intervals. 
TABLE  VII 
Nasal and Subcutaneous Tests  for Resistance, as Compared with Intracerebral 
No. of 
weekly sub- 
cutaneous 
injections 
of absorbed 
virus 
M.i.u. in each dose 
3 X 108 to3 X 104 
3 X 103 to3 X 104 
3 X 103 to3 X 104 
3 X l0  s to3 X 104 
3 X l0  s to3 X 1@ 
M.L.D. 
1-5 
1-5 
103-10  * 
10a-llY 
10~-llY 
Test for active immunity 
Given after last  immu- 
nizing  dose 
days 
23 
23 
12-30 
12-30 
12 days to 6mos. 
By way of 
Nose 
Subcutis 
Brain 
Result* 
1/10 
0/10 
9/12 
3/6 
0/90 
* Fractions defined in Table I.  All of fifty normal control  guinea  pigs  suc- 
cumbed to the test inoculations. 
Precipitated Virus as Immunizing Preparation 
The  type of precipitant  chosen for this  study was tannin  (tannic 
acid). 
Mode of Preparation.--The fresh brains  obtained from six mice which died of 
the experimental  disease were ground to an even suspension  in 90 ec. of sterile 
distilled water and spun in an angle centrifuge at 3,000 R.P.M. for 20 minutes.  To 
the supernatant fluid was added a sufficient amount of 2 per cent tannin to yield 
a  final  concentration  of 0.2 per cent.  The precipitate  formed  was  thoroughly 
agitated and the material placed in the cold for 18 to 24 hours.  It was then cen- 
trifuged  and the deposit  washed in 100 ce. of sterile  saline solution,  after which 
the precipitate was resuspended in 90 cc. of hormone broth, pH 7.6, and stored in 
the cold until used. 
The bacteria-free suspension in the usual dosages of 1 cc. gave rise to no nodules 
or other visible local reaction in the skin of guinea pigs, nor was the experimental 
disease induced in any of more than fifty animals employed for these tests.  Infec- 322  IMMUNIZATION  WITH ENCEPHALOMYELITIS VIRUS.  I 
tion arose, however, in guinea pigs and in mice after the tannin precipitated virus 
was introduced directly into the brain.  Precipitation by tannin, like adsorption 
by alumina, does not, therefore, inactivate the virus. 
Titration by means of guinea pig or mouse intracerebral test, of freshly prepared 
precipitate revealed as a  rule the presence of virus in dilutions up to 10 -4, and 
often higher.  Active virus was recovered from specimens stored in the cold as 
follows:  after 2 months, 30,000 m.i.u., after 3 months, 3,000 m.i.u., and after 3½ 
months, approximately 300 m.i.u. 
In the following experiments, the procedure in general followed  that hitherto 
employed. 
Immunization with Precipitated  Virus.--A summary of the  experi- 
mental results follows: 
When less than 3  X  103 to 3  ×  104 m.i.u, of such virus were injected subcu- 
taneously, it was found that guinea pigs were not protected against experimental 
intracerebral  infection  with  103  to  104  •.L.D.  A  single  injection  of  this  dose 
sufficed, however, to protect nine of ten guinea pigs against 1 to 5 M.L.D. given 
intranasally 2 to 4 weeks later, and all of five animals against these doses which 
are ordinarily lethal when injected subcutaneously.  So also, fifteen other guinea 
pigs acquired immunity to nose or skin infection by means of two and three im- 
munizing doses injected at weekly intervals.  For production of complete resist- 
ance to the introduction of 103 to 104 ~.L.D. into the brain, a rigorous  test, three 
such inocula at 7 day intervals were found necessary.  All of twenty animals were 
thus protected, as shown by their resistance to experimental infection on the 10th 
to the 90th day after the last immunizing dose, although of fifteen untreated ani- 
mals, all succumbed to the test inoculation. 
This immunizing capacity of the tannin preparation was maintained during its 
storage in the cold for at least 2 months, at which time the material contained at 
least 3  ×  104 m.i.u, per cc. 
During the period of immunization, nine of thirty-eight guinea pigs receiving 
this quantity of precipitated virus exhibited the familiar, transitory fever on the 
2nd to 4th day after inoculation, but in none was this accompanied by other signs 
of disease.  In one of twenty-five treated animals virus was found in the blood 
by the described method. 
Active tissue precipitated by tannin serves as an immunizing agent 
just as does adsorbed and unadsorbed mouse material.  No evidence 
was obtained to indicate that the infective agent in the tannin prepara- 
tion was inactivated by the process of precipitation, nor any that the 
rate of absorption of precipitated virus, subcutaneously injected, dif- 
fered from that of adsorbed or chemically untreated virus. PETER  K.  OLITSKY  AND  ~ERALD  1~. COX  323 
SUMMARY  AND  CONCLUSIONS 
Active Eastern or Western equine encephalomyelifisvirus  in  three 
forms,--chemically untreated but simply passaged through series  of 
mice; adsorbed on alumina Gel C, and precipitated  by tannin,-- 
yielded practically the same results when employed for the immuniza- 
tion of guinea pigs. 
The virus is not inactivated by the process of adsorption or precipi- 
tation: guinea pigs and mice inoculated in the brain with these mate- 
rials develop lethal encephalomyelitis in the same manner as when 
chemically untreated mouse passage virus has been used.  Moreover, 
there is no difference in the rate of absorption in viva of the chemically 
treated and untreated virus preparations.  Mter storage of the three 
immunizing preparations--the longest periods thus far studied being 
2 to 3 months for mouse passage and for precipitated suspensions, and 
6 months for adsorbed material--each was found to contain an amount 
of virus sufficient to produce immunity in animals against the usual 
intracerebral  test  inoculation.  Finally,  the protection afforded by 
the three preparations is apparently durable, as is true of many active 
viruses utilized in preventive treatments. 
The amount of the virus necessary to  confer protection may be 
defined as that which immunizes (a) with the least number of antigenic 
units and (b) with the minimum  of febrile reaction and blood infection. 
In proportion as this amount is exceeded, the incidence of fever and of 
circulating virus increases and, on the other hand, as this amount is 
decreased, the degree of induced immunity is diminished. 
We have thus shown that for this particular virus and in the guinea 
pig, one or two subcutaneous doses of 1 cc. of any of the different virus 
preparations, each containing 3 ×  103 to 3 X 104 mouse infective units, 
bring about protection regularly against experimental infection by 
way of the nose or subcutis.  The results are irregular when the test 
is made by way of the brain.  By three injections, resistance is invari- 
ably obtained against as many as 103 to 104 lethal doses, given intra- 
cerebrally. 
No matter in what form the virus is given, as mouse passage, or 
adsorbed, or precipitated material, in certain instances fever occurs 
and virus circulates.  With the amount of virus adequate for immuni- 324  IMMUNIZATION  WITH  ENCEPHALOM~-r]ELITIS  VIRUS.  I 
zation (3,000 to 30,000 m.i.u.) a mild or subclinical infection may occur 
in  the  guinea  pig  without  other  manifestation  of  disease.  Lesser 
quantities of virus apparently fail to gain a foothold in the animal and 
thus fail to bring  about resistance. 
To conclude, a quantitative basis has been established for the com- 
parison  of  the  immunizing  capacities  of  preparations  employed  in 
experimental equine encephalomyelitis in guinea pigs. 
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